Skip to main content
. 2020 Apr 29;45(10):1743–1749. doi: 10.1038/s41386-020-0683-2

Fig. 1. Cognitive performance at baseline of bipolar disorder patients taking lithium (N = 169) vs. those not taking lithium (N = 93) were compared across six neurocognitive tests (CVLT trials 1–5, CVLT delayed recall, Digit Symbol, COWAT, TMT-A, and TMT-B) and a global cognitive index.

Fig. 1

Scores are expressed as Z scores with a mean of 0 and standard deviation of 1 and were calculated within the BD sample. Error bars are depicted to describe variability of the data.